메뉴 건너뛰기




Volumn 6, Issue 7, 2004, Pages 415-419

Chemotherapy in gastric cancer: A brief chronicle with emphasis on recent developments

Author keywords

Adjuvant therapy; Chemotherapy; Gastric cancer; Metastatic disease; New drugs

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ATROPINE; CAPECITABINE; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; NITROSOUREA; OXALIPLATIN; PACLITAXEL; TEGAFUR; UFT;

EID: 3242886300     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (39)
  • 1
    • 0018931354 scopus 로고
    • 5-fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer
    • Macdonald J, Schein P, Woolley P. 5-fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980;93:533-6.
    • (1980) Ann. Intern. Med. , vol.93 , pp. 533-536
    • Macdonald, J.1    Schein, P.2    Woolley, P.3
  • 2
    • 84944367593 scopus 로고
    • A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: Fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin and mitomycin
    • Cullinan S, Moertel C, Fleming T. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin and mitomycin. JAMA 1985;253:2061-7.
    • (1985) JAMA , vol.253 , pp. 2061-2067
    • Cullinan, S.1    Moertel, C.2    Fleming, T.3
  • 3
    • 0028959887 scopus 로고
    • Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
    • Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587-91.
    • (1995) Br. J. Cancer , vol.71 , pp. 587-591
    • Pyrhonen, S.1    Kuitunen, T.2    Nyandoto, P.3    Kouri, M.4
  • 4
    • 0024454042 scopus 로고
    • Phase II study with the combination of etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer
    • Preusser P, Wilke H. Achterrath W. Phase II study with the combination of etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989;7:1310-17.
    • (1989) J. Clin. Oncol. , vol.7 , pp. 1310-1317
    • Preusser, P.1    Wilke, H.2    Achterrath, W.3
  • 5
    • 0022902979 scopus 로고
    • An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) in advanced measurable gastric cancer
    • Wils J, Bleiberg H, Dalesio O. An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) in advanced measurable gastric cancer. J Clin Oncol 1986;4:1799-803.
    • (1986) J. Clin. Oncol. , vol.4 , pp. 1799-1803
    • Wils, J.1    Bleiberg, H.2    Dalesio, O.3
  • 6
    • 0025762832 scopus 로고
    • Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - A step ahead in the treatment of advanced gastric cancer: A trial of the EORTC's Gastrointestinal Tract Cooperative Group
    • Wils J, Klein H, Wegener DJT. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the EORTC's Gastrointestinal Tract Cooperative Group. J Clin Oncol 1991;9:827-31.
    • (1991) J. Clin. Oncol. , vol.9 , pp. 827-831
    • Wils, J.1    Klein, H.2    Wegener, D.J.T.3
  • 7
    • 0026548710 scopus 로고
    • FAMTX versus etoposide, doxorubicin and cisplatin: A random assignment trial in gastric cancer
    • Kelsen D, Atiq OT, Saltz L, Niedzwiecki D. FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 1992;10:541-8.
    • (1992) J. Clin. Oncol. , vol.10 , pp. 541-548
    • Kelsen, D.1    Atiq, O.T.2    Saltz, L.3    Niedzwiecki, D.4
  • 8
    • 0031022803 scopus 로고    scopus 로고
    • Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer
    • Webb A, Cunningham D, Scarffe JH. Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997;15:261-7.
    • (1997) J. Clin. Oncol. , vol.15 , pp. 261-267
    • Webb, A.1    Cunningham, D.2    Scarffe, J.H.3
  • 9
    • 0036671779 scopus 로고    scopus 로고
    • Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001
    • Hasham-Jiwa N, Kasakura Y, Ajani JA. Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001. Int J Clin Oncol 2002;7:219-24.
    • (2002) Int. J. Clin. Oncol. , vol.7 , pp. 219-224
    • Hasham-Jiwa, N.1    Kasakura, Y.2    Ajani, J.A.3
  • 10
    • 0028487470 scopus 로고
    • Docetaxel (Taxotere) in advanced gastric cancer: Results of a phase II clinical trial
    • EORTC Early Clinical Trials Group
    • Sulkes A, Smith J, Sessa C. Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. Br J Cancer 1994;70:380-3.
    • (1994) Br. J. Cancer , vol.70 , pp. 380-383
    • Sulkes, A.1    Smith, J.2    Sessa, C.3
  • 11
    • 0034154069 scopus 로고    scopus 로고
    • Docetaxel (Taxotere)-cisplatin: An effective drug combination in gastric carcinoma
    • Swiss Group for Clinical Cancer Research (SAAK), and the European Institute of Oncology
    • Roth AD, Maibach R, Martinelli G. Docetaxel (Taxotere)-cisplatin: an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAAK), and the European Institute of Oncology. Ann Oncol 2000;11:301-6.
    • (2000) Ann. Oncol. , vol.11 , pp. 301-306
    • Roth, A.D.1    Maibach, R.2    Martinelli, G.3
  • 12
    • 0346790006 scopus 로고    scopus 로고
    • Docetaxel, cisplatin, 5-fluorouracil compared to cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma. Interim results of a randomized phase III trial (V325)
    • Ajani JA, Van Cutsem E, Moiseyenko V. Docetaxel, cisplatin, 5-fluorouracil compared to cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma. Interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 2003;22:249.
    • (2003) Proc. Am. Soc. Clin. Oncol. , vol.22 , pp. 249
    • Ajani, J.A.1    Van Cutsem, E.2    Moiseyenko, V.3
  • 13
    • 0029550022 scopus 로고
    • Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract, the Eastern Cooperative Oncology Group (ECOG) results
    • Einsig AI, Lipsitz S, Wiernik PH, Benson AB. Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract, the Eastern Cooperative Oncology Group (ECOG) results. Invest New Drugs 1995;13:223-7.
    • (1995) Invest. New Drugs , vol.13 , pp. 223-227
    • Einsig, A.I.1    Lipsitz, S.2    Wiernik, P.H.3    Benson, A.B.4
  • 14
    • 18544381911 scopus 로고    scopus 로고
    • Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer
    • Kornek GV, Raderer M. Schull B, Fiebiger W. Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer. Br J Cancer 2002;86:1858-63.
    • (2002) Br. J. Cancer , vol.86 , pp. 1858-1863
    • Kornek, G.V.1    Raderer, M.2    Schull, B.3    Fiebiger, W.4
  • 15
    • 0035987101 scopus 로고    scopus 로고
    • Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3 weekly cisplatin for the treatment of patients with advanced gastric cancer
    • Honecker F, Kollmannsberger C, Quietzsch D, Haag C. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3 weekly cisplatin for the treatment of patients with advanced gastric cancer. Anticancer Drugs 2002;13:497-503.
    • (2002) Anticancer Drugs , vol.13 , pp. 497-503
    • Honecker, F.1    Kollmannsberger, C.2    Quietzsch, D.3    Haag, C.4
  • 16
    • 0001095834 scopus 로고    scopus 로고
    • Final results of a phase II trial of CPT-11 in patients with advanced gastric cancer
    • Kohne CH, Thuss-Patience P, Catane R. Final results of a phase II trial of CPT-11 in patients with advanced gastric cancer. Proc Am Soc Clin Oncol 1999;18:258.
    • (1999) Proc. Am. Soc. Clin. Oncol. , vol.18 , pp. 258
    • Kohne, C.H.1    Thuss-Patience, P.2    Catane, R.3
  • 17
    • 0036561832 scopus 로고    scopus 로고
    • Irinotecan/cisplatin in advanced treated gastric or gastroesophageal junction carcinoma
    • Ajani JA, Baker J, Pisters PW, Ho L. Irinotecan/cisplatin in advanced treated gastric or gastroesophageal junction carcinoma. Oncology 2002;16:8-16.
    • (2002) Oncology , vol.16 , pp. 8-16
    • Ajani, J.A.1    Baker, J.2    Pisters, P.W.3    Ho, L.4
  • 18
    • 0036468440 scopus 로고    scopus 로고
    • CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma
    • Ajani JA, Baker J, Pisters PW, Ho L. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma. Cancer 2002;94:641-6.
    • (2002) Cancer , vol.94 , pp. 641-646
    • Ajani, J.A.1    Baker, J.2    Pisters, P.W.3    Ho, L.4
  • 19
    • 0242356584 scopus 로고    scopus 로고
    • Randomized phase II trial of docetaxel plus irinotecan versus docetaxel plus 5-fluorouracil, in patients with untreated advanced gastric adenocarcinoma
    • Hawkins R, Cunningham D, Soerbye H. Randomized phase II trial of docetaxel plus irinotecan versus docetaxel plus 5-fluorouracil, in patients with untreated advanced gastric adenocarcinoma. Proc Am Soc Clin Oncol 2003;22:257.
    • (2003) Proc. Am. Soc. Clin. Oncol. , vol.22 , pp. 257
    • Hawkins, R.1    Cunningham, D.2    Soerbye, H.3
  • 20
    • 0031879628 scopus 로고    scopus 로고
    • Uracil-Tagafur in gastric carcinoma: A comprehensive review
    • Takiuchi H, Ajani JA. Uracil-Tagafur in gastric carcinoma: a comprehensive review. J Clin Oncol 1998;16:2877-85.
    • (1998) J. Clin. Oncol. , vol.16 , pp. 2877-2885
    • Takiuchi, H.1    Ajani, J.A.2
  • 21
    • 8044231966 scopus 로고    scopus 로고
    • Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the Oncopaz Cooperative Group
    • Feliu J, Baron MG, Garcia-Giron C. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the Oncopaz Cooperative Group. Cancer 1996;78:211-16.
    • (1996) Cancer , vol.78 , pp. 211-216
    • Feliu, J.1    Baron, M.G.2    Garcia-Giron, C.3
  • 22
    • 0032801832 scopus 로고    scopus 로고
    • Epirubicin, cisplatin and oral UFT with leucovorin (ECU): A phase I-II study in patients with advanced upper gastrointestinal tract cancer
    • Seymour M, Dent JT, Papamichael D. Epirubicin, cisplatin and oral UFT with leucovorin (ECU): a phase I-II study in patients with advanced upper gastrointestinal tract cancer Ann Oncol 1999;10:1329-33.
    • (1999) Ann. Oncol. , vol.10 , pp. 1329-1333
    • Seymour, M.1    Dent, J.T.2    Papamichael, D.3
  • 23
    • 0036926036 scopus 로고    scopus 로고
    • Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    • Kim TW, Kang YK, Ahn JH. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer. Ann Oncol 2002;13:1893-8.
    • (2002) Ann. Oncol. , vol.13 , pp. 1893-1898
    • Kim, T.W.1    Kang, Y.K.2    Ahn, J.H.3
  • 24
    • 0036740439 scopus 로고    scopus 로고
    • A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable esophagogastric adenocarcinoma
    • Evans TR, Pentheroudakis G, Paul S, McInnes A. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable esophagogastric adenocarcinoma. Ann Oncol 2002;13:1469-78.
    • (2002) Ann. Oncol. , vol.13 , pp. 1469-1478
    • Evans, T.R.1    Pentheroudakis, G.2    Paul, S.3    McInnes, A.4
  • 25
    • 0036893770 scopus 로고    scopus 로고
    • Phase II study of oxaliplatin, fluorouracil and folinic acid in locally advanced or metastatic gastric cancer patients
    • Louvet C, Andre T, Tigaud JM, Gamelin E. Phase II study of oxaliplatin, fluorouracil and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002;20:4543-8.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 4543-4548
    • Louvet, C.1    Andre, T.2    Tigaud, J.M.3    Gamelin, E.4
  • 26
    • 0037352255 scopus 로고    scopus 로고
    • Phase II study of oxaliplatin, 5 fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
    • Kim DY, Kim JH, Lee SH. Phase II study of oxaliplatin, 5 fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol 2003;14:383-7.
    • (2003) Ann. Oncol. , vol.14 , pp. 383-387
    • Kim, D.Y.1    Kim, J.H.2    Lee, S.H.3
  • 27
    • 12244249161 scopus 로고    scopus 로고
    • Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer
    • Grau JJ, Martin M, Fuster J, Pera M. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer. J Surg Oncol 2003;82:234-40.
    • (2003) J. Surg. Oncol. , vol.82 , pp. 234-240
    • Grau, J.J.1    Martin, M.2    Fuster, J.3    Pera, M.4
  • 28
    • 0027248855 scopus 로고
    • Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials
    • Hermans J, Bonenkamp JJ, Boon MC, Bunt AM. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11:1441-7.
    • (1993) J. Clin. Oncol. , vol.11 , pp. 1441-1447
    • Hermans, J.1    Bonenkamp, J.J.2    Boon, M.C.3    Bunt, A.M.4
  • 29
    • 0033166516 scopus 로고    scopus 로고
    • Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients. Revisiting a meta-analysis of randomized trials
    • Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients. Revisiting a meta-analysis of randomized trials. Eur J Cancer 1999;35:1059-64.
    • (1999) Eur. J. Cancer , vol.35 , pp. 1059-1064
    • Earle, C.C.1    Maroun, J.A.2
  • 30
    • 0033816806 scopus 로고    scopus 로고
    • Efficacy of adjuvant chemotherapy after curative resection for gastric cancer. A meta-analysis of published randomized trials. A study of the GISCAD Group
    • Mari E, Floriani I, Tinazzi A. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer. A meta-analysis of published randomized trials. A study of the GISCAD Group. Ann Oncol 2000;11:837-43.
    • (2000) Ann. Oncol. , vol.11 , pp. 837-843
    • Mari, E.1    Floriani, I.2    Tinazzi, A.3
  • 31
    • 0035434280 scopus 로고    scopus 로고
    • Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer
    • Gianni L, Panzini I, Tassinari D. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 2001;12:1178-80.
    • (2001) Ann. Oncol. , vol.12 , pp. 1178-1180
    • Gianni, L.1    Panzini, I.2    Tassinari, D.3
  • 32
    • 0035818048 scopus 로고    scopus 로고
    • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
    • Macdonald JS, Smalley SR, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
    • (2001) N. Engl. J. Med. , vol.345 , pp. 725-730
    • Macdonald, J.S.1    Smalley, S.R.2    Benedetti, J.3
  • 33
    • 3242893117 scopus 로고    scopus 로고
    • Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin and infusional 5FU (ECF) before and after CI 5-FU and radiotherapy: A multicenter pilot study
    • Fuchs C, Fitzgerald T, Mamon H. Postoperative adjuvant chemoradiation for gastric or gastroesophageal adenocarcinoma using epirubicin, cisplatin and infusional 5FU (ECF) before and after CI 5-FU and radiotherapy: A multicenter pilot study. Proc Am Soc Clin Oncol 2003;22:257.
    • (2003) Proc. Am. Soc. Clin. Oncol. , vol.22 , pp. 257
    • Fuchs, C.1    Fitzgerald, T.2    Mamon, H.3
  • 34
    • 0038298071 scopus 로고    scopus 로고
    • Future strategies and adjuvant treatment of gastric cancer
    • Falcone A. Future strategies and adjuvant treatment of gastric cancer. Ann Oncol 2003;14:45-7.
    • (2003) Ann. Oncol. , vol.14 , pp. 45-47
    • Falcone, A.1
  • 35
    • 0030451795 scopus 로고    scopus 로고
    • Phase II trial of docetaxel (taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group results of protocol E 1293
    • Einzig AI, Neuberg D, Remick SC. Phase II trial of docetaxel (taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group results of protocol E 1293. Med Oncol 1996;1113:87-93.
    • (1996) Med. Oncol. , vol.1113 , pp. 87-93
    • Einzig, A.I.1    Neuberg, D.2    Remick, S.C.3
  • 36
    • 0034449134 scopus 로고    scopus 로고
    • Front-line treatment of advanced gastric cancer with docetaxel and granulocyte colony stimulating factor (G-CSF): A phase II trial
    • Mavroudis D, Kourousis C, Androulakis N. Front-line treatment of advanced gastric cancer with docetaxel and granulocyte colony stimulating factor (G-CSF): a phase II trial. Am J Clin Oncol 2000;23: 341-4.
    • (2000) Am. J. Clin. Oncol. , vol.23 , pp. 341-344
    • Mavroudis, D.1    Kourousis, C.2    Androulakis, N.3
  • 37
    • 0036654749 scopus 로고    scopus 로고
    • 2 is active and well-tolerated in patients with metastatic or recurrent gastric cancer: A phase II trial
    • 2 is active and well-tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial. Jpn J Clin Oncol 2000;32:248-54.
    • (2000) Jpn. J. Clin. Oncol. , vol.32 , pp. 248-254
    • Bang, Y.J.1    Kang, W.K.2    Kang, Y.K.3
  • 38
    • 18144450345 scopus 로고    scopus 로고
    • Late phase II clinical study of docetaxel in patients with advanced/recurrent gastric cancer: A Japanese Cooperative Study Group Trial
    • Taguchi T, Sakata Y, Kanamaru R. Late phase II clinical study of docetaxel in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group Trial. Gan To Kagaku Ryoho 1998;25:1915-25.
    • (1998) Gan To Kagaku Ryoho , vol.25 , pp. 1915-1925
    • Taguchi, T.1    Sakata, Y.2    Kanamaru, R.3
  • 39
    • 0000149185 scopus 로고    scopus 로고
    • Phase II study of docetaxel as second line chemotherapy in metastatic gastric cancer
    • Vanhoefer U, Wilke H, Harstrick A. Phase II study of docetaxel as second line chemotherapy in metastatic gastric cancer. Proc Am Soc Clin Oncol 1999;18:1163.
    • (1999) Proc. Am. Soc. Clin. Oncol. , vol.18 , pp. 1163
    • Vanhoefer, U.1    Wilke, H.2    Harstrick, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.